DILACOR XR
DILTIAZEM HYDROCHLORIDE
Approval overview DILACOR XR is listed in Drugs@FDA under application 020092 (NDA).
Review priority: UNKNOWN Marketing status: Discontinued Active ingredient DILTIAZEM HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2011-06-07 00:00:00.
Structured Monograph
Clinical summary
Approval overview DILACOR XR is listed in Drugs@FDA under application 020092 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient DILTIAZEM HYDROCHLORIDE Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALLERGAN Submission history Latest submission status date: 2011-06-07 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.